The Promise of Cocoamind
For better or worse, it looks like cacao as a nutraceutical is on its way into products, courtesy of French plant-chemistry company Groupe Berkem’s latest effort: cocoamind.
Berkem’s latest innovation features cacao specifically sourced from non-fermented and non-roasted cocoa beans. The company claims their extract targets cognitive and emotional support simultaneously. Four boosts from one ingredient, that’s the sell: focus, memory, mood, and well-being. Throw in a little comfy familiarity (everyone knows chocolate), and there you have it, cocoamind is here.
Image Credit: Groupe Berkem
It’s smart marketing because it positions Cocoamind as the anti-complexity supplement in a market drowning in 27-ingredient stacks that promise everything to everyone. We’ll certainly give them a B+ for potential, but let’s take a closer look…
Cocoamind and the 105-Person Study
Here’s what we do know: Groupe Berkem ran a two-month pilot with 105 participants. They measured concentration, memory, mood, and emotional well-being using “scientifically recognized questionnaires.” Benefits appeared within the first month. And yes, you’re not alone if you just laughed at the term “scientifically recognized questionnaires.”
Here’s what we don’t know: basically everything else that makes a study meaningful. Was there a control group? Placebo control? Double-blind methodology? What was the dosage? How were participants recruited — did they volunteer knowing they were testing a mood supplement (which can introduce bias)? Were there dropout rates? Adverse events? What’s the actual effect size? A statistically significant improvement in scientifically recognized questionnaires doesn’t necessarily mean meaningful relief from anxiety or depression.
In other words, a 105-person, two-month pilot is preliminary data. It’s useful, sure, but it’s certainly not proof by any stretch of the imagination, and “Conducted a small pilot study that showed promise” doesn’t fit on a supplement bottle.
Those kind of results warrant a larger, properly controlled study to boost cocoamind to that serious, ready-for-primetime level. Now I’m not saying cocoamind doesn’t work, of course not. I’m simply saying we don’t actually know if it does, and the distinction matters when we’re making purchasing decisions about our mental health. Any of you familiar with my work over at Change the World Films (and particularly on frontotemopral dementia) know that I don’t take such important distinctions lightly. Ever.
The Quest for Clarity
We don’t have any word yet on where cocoamind will land, so perhaps by the time it starts appearing in products, further clinical data will indeed be available. For now, we know that cocoa does contain compounds — theobromine, phenylethylamine, serotonin precursors — that plausibly affect mood and cognition. For cocoamind, the question may be about bioavailability and dose. Eating a chocolate bar gives you some of these compounds in negligible amounts. Extracting and concentrating them likely changes the equation, and perhaps for the better.
However, a consumer who feels better after taking a cocoa supplement might feel better because they’ve committed to their mental health (placebo effect), not because the cocoa extract is uniquely effective. That’s another concern I’d like to see addressed as well.
The nutraceutical industry sometimes thrives on this ambiguity. You can make claims about “supporting” mood and cognition, language that sounds impressive but legally commits you to almost nothing. If Cocoamind actually reversed depression or meaningfully improved ADHD symptoms, Berkem would be required to submit to FDA oversight and prove it works. Instead, it lives in the supplemental sweet spot: plausible enough to seem credible, vague enough to avoid scrutiny.
Berkem’s Bottom Line: Time Will Tell
I would love for innovative cocoa-based wellness ingredients to exist. Cocoa farming needs more value-add opportunities, and if plant-chemistry companies can develop functional extracts that genuinely help people manage stress or sharpen focus, that’s real progress. I’ll save any excitement, however, for when its not simply wrapped in preliminary data and marketing language.
Berkem’s got an interesting ingredient concept here with cocoamind, and I look forward to learning more. Now they need to prove it’s something beyond just cocoa-flavored marketing.
